GE Healthcare of Chalfont St. Giles, U.K., has unveiled its new SenoBright contrast-enhanced spectral mammography (CESM) system, designed to reduce ambiguity in mammography results and help detect and diagnose cancer.
SenoBright is an upgrade to GE's Senographe DS and Senographe Essential full-field digital mammography (FFDM) units. The technology produces x-rays at multiple energies to create two separate exposures, which illuminate and highlight areas where there is growth of small blood vessels potentially related to the presence of cancer.
The technology was created through a collaboration between GE and Qatar Science & Technology Park, which hosts a group of technology-based companies from around the world and serves as an incubator for start-up enterprises.
SenoBright has not yet received clearance for use in Europe or the U.S.
Related Reading
GE touts Visipaque study results, May 27, 2010
GE launches CT scanner in Europe, May 25, 2010
GE hits healthymagination goals, May 24, 2010
GE touts ADMIRE-HF trial results, May 21, 2010
GE partners with CardioDx on diagnostics, May 13, 2010
Copyright © 2010 AuntMinnie.com
